« Back
Home /
Omeprazole (H 16868)

Omeprazole (H 16868)

Item no.	M1834-2g
Manufacturer	AbMole
CASRN	73590-58-6
Amount	2g
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer
Type	Inhibitors
Specific against	other
Purity	0,9994
Citations	Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis. Rezin, et al . Basic Clin Pharmacol Toxicol. 2011 Mar,108(3):214-9. PMID: 21138529 . Omeprazol and ezomeprazol pharmacokinetics, duration of antisecretory effect, and reasons for their probable changes in duodenal ulcer. Serebrova, et al . Eksp Klin Gastroenterol. 2009,(4):86-92. PMID: 19960999 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	H 16868; Omeprazol
Similar products	Omeprazol, Omeprazole
Available
Target Information	Proton Pump
Molecular Weight	345, 42
Solubility	DMSO 80 mg/mL
Bioactivity information	Omeprazol is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, laryngopharyngeal reflux (LPR) and Zollinger–Ellison syndrome.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1834-2g-safety-datasheet.pdf